Celltrion Seeks FDA Approval for Biosimilar Remsima

April 1, 2015 7:34 AM

15 0

Celltrion Seeks FDA Approval for Biosimilar Remsima

The Korea-based company hopes its biosimilar drug will be approved for sale in the U.S. by the third quarter

SEOUL—Celltrion Inc., which sells a cheap version of a top-selling rheumatoid arthritis drug in Europe, is now setting its sights on the U.S., the world’s biggest pharmaceutical market.

Also read: After Italian Prime Minister Renzi’s defeat, this Trump fan could throw Europe into crisis

Read more

To category page

Loading...